fashion -WSS

fashion

author：explore 2025-10-01 23:01:57 - browse：68563

From left, STAT's Allison DeAngelis, ALS advocate Cathy Collet, Yale's Gregg Gonsalves, Sick Cells' Ashley Valentine, and Canary Advisors' Jennifer McNary at a panel at the 2024 STAT Breakthrough Summit East. STAT

NEW YORK — Over 30 years ago, Gregg Gonsalves and other AIDS activists persuaded Congress to create the accelerated approval pathway, allowing regulators to speed access to drugs for thousands of dying patients.

These days, though, Gonsalves sounds uneasy — if not mournful — of the world he helped build.

“We’re approving drugs faster and faster — [the FDA is] one of the fastest regulatory agencies in the world — we know less and less about them, and we pay more and more for them,” said Gonsalves, now a professor at Yale, at STAT Breakthrough Summit East on Thursday. “So in that way, the system is not working. We basically put access out there as this talisman of hope, but we don’t compel the companies that give us answers about what these drugs do in our bodies.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Sen. Paul opposes bill to ban Chinese biotechs

WSS

Change Healthcare cyberattack prompts Medicare loan program

In his State of the Union, Biden takes clear aim at 'Big Pharma'

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

First medicine developed to treat MASH expected to be approved soon

Novo Nordisk obesity pill bests Wegovy in early trial

hotspot

fashion

focus

Bright Health sells Medicare Advantage business to Molina

Change Healthcare payments predicted restored March 15

Walensky prepares to leave CDC — and Congress — behind

It's time to take a new tack for treating Alzheimer's

Medical records are filled with copy

NEJM study link tiny plastics in blood vessels to heart problems

Activists slam private health insurers over coverage restrictions

First medicine developed to treat MASH expected to be approved soon

Malaria cases in Florida and Texas: Here’s what you need to know

Former medical device CEO who sold dummy, plastic parts convicted of fraud

hotspot

UnitedHealth quietly bought dozens of outpatient centers

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

The problem with charging patients to message their doctors

Novo Nordisk obesity pill bests Wegovy in early trial

With psoriasis trial ahead, Alumis raises $259 million

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

leisure time

Wikipedia

explore

hotspot